日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

转移性激素敏感性前列腺癌原发性前列腺肿瘤的转录组分析及其与临床结局的关联:E3805 CHAARTED试验的相关性分析

Hamid, A A; Huang, H-C; Wang, V; Chen, Y-H; Feng, F; Den, R; Attard, G; Van Allen, E M; Tran, P T; Spratt, D E; Dittamore, R; Davicioni, E; Liu, G; DiPaola, R; Carducci, M A; Sweeney, C J

Naming disease states for clinical utility in prostate cancer: a rose by any other name might not smell as sweet

前列腺癌疾病状态的命名及其临床实用性:玫瑰换个名字可能就不那么香了。

Armstrong, A J; Antonarakis, E S; Taplin, M-E; Kelly, W K; Beltran, H; Fizazi, K; Dahut, W L; Shore, N; Slovin, S; George, D; Carducci, M A; Corn, P; Danila, D; Dreicer, R; Heath, E; Rathkopf, D; Liu, G; Nanus, D; Stein, M; Smith, M R; Sternberg, C; Wilding, G; Nelson, P S; Halabi, S; Kantoff, P; Clarke, N W; Evans, C P; Heidenreich, A; Mottet, N; Gleave, M; Morris, M J; Scher, H I

A review of pomegranate in prostate cancer

石榴在治疗前列腺癌中的应用综述

Paller, C J; Pantuck, A; Carducci, M A

Transforming the Perioperative Treatment Paradigm in Non-Metastatic RCC-A Possible Path Forward

转变非转移性肾细胞癌的围手术期治疗模式——一条可能的未来发展路径

Harshman, L C; Drake, C G; Haas, N B; Manola, J; Puligandla, M; Signoretti, S; Cella, D; Gupta, R T; Bhatt, R; Van Allen, E; Lara, P; Choueiri, T K; Kapoor, A; Heng, D Y C; Shuch, B; Jewett, M; George, D; Michaelson, D; Carducci, M A; McDermott, D; Allaf, M

Serial blood-based analysis of AR-V7 in men with advanced prostate cancer

对晚期前列腺癌男性患者进行基于血液的AR-V7系列分析

Nakazawa, M; Lu, C; Chen, Y; Paller, C J; Carducci, M A; Eisenberger, M A; Luo, J; Antonarakis, E S

The effect of the frequency and duration of PSA measurement on PSA doubling time calculations in men with biochemically recurrent prostate cancer

前列腺癌生化复发患者中,PSA检测频率和持续时间对PSA倍增时间计算的影响

Paller, C J; Olatoye, D; Xie, S; Zhou, X; Denmeade, S R; Eisenberger, M A; Antonarakis, E S; Carducci, M A; Rosner, G L

A randomized phase II study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer

一项针对接受局部前列腺癌初始治疗后PSA升高男性患者的石榴提取物随机II期研究

Paller, C J; Ye, X; Wozniak, P J; Gillespie, B K; Sieber, P R; Greengold, R H; Stockton, B R; Hertzman, B L; Efros, M D; Roper, R P; Liker, H R; Carducci, M A

Pharmacodynamic study of disulfiram in men with non-metastatic recurrent prostate cancer

双硫仑治疗非转移性复发性前列腺癌男性患者的药效学研究

Schweizer, M T; Lin, J; Blackford, A; Bardia, A; King, S; Armstrong, A J; Rudek, M A; Yegnasubramanian, S; Carducci, M A

A phase I/IIA study of AGS-PSCA for castration-resistant prostate cancer

一项针对去势抵抗性前列腺癌的 AGS-PSCA I/IIA 期研究

Morris, M J; Eisenberger, M A; Pili, R; Denmeade, S R; Rathkopf, D; Slovin, S F; Farrelly, J; Chudow, J J; Vincent, M; Scher, H I; Carducci, M A

Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours.

组蛋白去乙酰化酶抑制剂恩替诺特联合 13-顺式维甲酸治疗实体瘤患者的 I 期研究

Pili R, Salumbides B, Zhao M, Altiok S, Qian D, Zwiebel J, Carducci M A, Rudek M A